Glycerol-3-phosphate phosphatase operates a glycerol shunt in pancreatic β-cells that controls insulin secretion and metabolic stress.
Glucodetoxification
Glucose-stimulated insulin secretion
Glycerol shunt
Glycerol-3-phosphate phosphatase
Obesity
Pancreatic beta cell
Type 2 diabetes
Journal
Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
13
01
2022
revised:
20
02
2022
accepted:
03
03
2022
pubmed:
11
3
2022
medline:
11
5
2022
entrez:
10
3
2022
Statut:
ppublish
Résumé
The recently identified glycerol-3-phosphate (Gro3P) phosphatase (G3PP) in mammalian cells, encoded by the PGP gene, was shown to regulate glucose, lipid and energy metabolism by hydrolyzing Gro3P and to control glucose-stimulated insulin secretion (GSIS) in β-cells, in vitro. However, whether G3PP regulates β-cell function and insulin secretion in vivo is not known. We now examined the role of G3PP in the control of insulin secretion in vivo, β-cell function and glucotoxicity in inducible β-cell specific G3PP-KO (BKO) mice. Inducible BKO mice were generated by crossing floxed-G3PP mice with Mip-Cre-ERT (MCre) mice. All the in vivo studies were done using BKO and control mice fed normal diet and the ex vivo studies were done using pancreatic islets from these mice. BKO mice, compared to MCre controls, showed increased body weight, adiposity, fed insulinemia, enhanced in vivo GSIS, reduced plasma triglycerides and mild glucose intolerance. Isolated BKO mouse islets incubated at high (16.7 mM), but not at low or intermediate glucose (3 and 8 mM), showed elevated GSIS, Gro3P content as well as increased levels of metabolites and signaling coupling factors known to reflect β-cell activation for insulin secretion. BKO islets also showed reduced glycerol release and increased O The results demonstrate that β-cells are endowed with a "glycerol shunt", operated by G3PP that regulates β-cell metabolism, signaling and insulin secretion in vivo, primarily at elevated glucose concentrations. We propose that the glycerol shunt plays a role in preventing insulin hypersecretion and excess body weight gain and contributes to β-cell mass preservation in the face of hyperglycemia.
Identifiants
pubmed: 35272070
pii: S2212-8778(22)00040-0
doi: 10.1016/j.molmet.2022.101471
pmc: PMC8972011
pii:
doi:
Substances chimiques
Insulin
0
Phosphates
0
Phosphoric Monoester Hydrolases
EC 3.1.3.2
Glucose
IY9XDZ35W2
Glycerol
PDC6A3C0OX
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101471Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier GmbH.. All rights reserved.